Medical

Medicines Australia and MTAA welcome Government support for harmonisation of clinical trials

Health Industry Hub | July 3, 2020 |
[Total: 1    Average: 5/5]

Medical News: Medicines Australia and Medical Technology Association of Australia (MTAA) welcome the announcement from the Minister for Health, the Hon Greg Hunt MP, during his CEDA address that he will be asking the National Cabinet to expedite “a one stop shop” for ethics approval of clinical trials in Australia.

Medicines Australia said while improvements to R&D tax incentive policy settings also remain essential, harmonisation of the arrangements surrounding clinical trials nationwide are vital if we are to increase investment in this critical area and ensure a health-led economic recovery from the COVID-19 pandemic. This reform will mean a healthier Australia along with investment in Australian jobs and economic growth.

“The medical technology industry has long advocated for national harmonisation of clinical trials and welcomes Minister Hunt’s announcement of a one-stop-shop for ethics approval,” said Ian Burgess, MTAA CEO.

“Local clinical trials provide Australian patients with early access to innovative medical devices and treatments and place Australia at the forefront of global advancements of medical technology.

“An active medical device clinical trial environment in Australia will provide local expertise to support Australian start-ups and research groups, accelerating their growth and retaining capability and expertise within Australia,” Mr Burgess said.

As governments, state and federal, consider the steps required to ensure a healthy Australia as we emerge from the worst of the COVID-19 crisis, the innovative pharmaceutical companies represented by Medicines Australia are playing their part in contributing to the global effort to develop a vaccine and improve Australia’s prospects of its being delivered to our citizens in a timely and equitable fashion.

Minister Hunt’s announcement, if adopted by National Cabinet, would enhance the attraction of Australia as a destination for clinical trials for all innovative medicines and therapies. Premiers and Chief Ministers can take action to deliver consistency within and between jurisdictions. Their action will decrease complexity and increase speed of commencement of clinical trials and encourage new trials to be initiated, generating further jobs, economic growth and social improvements.

With our general success so far regarding COVID-19, Australia is well-placed to be ‘open for business’ on clinical trials at a time when many other parts of the globe have had to halt trials due to hospitals and clinical staff being overwhelmed.

Medicines Australia and MTAA look forward to working with Minister Hunt, the Department of Health and State and Territory Governments on this important initiative.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - State first heart procedure with non-invasive technology most commonly used to combat cancer

State first heart procedure with non-invasive technology most commonly used to combat cancer

Health Industry Hub | August 4, 2020 |

MedTech News: A team of cardiologists and radiation oncologists from Fiona Stanley Hospital (FSH) and GenesisCare, have become the first […]

More


News & Trends - Pharmaceuticals

Pharma News - Medicines Australia calls for a focus in planning Australia's future in health

Medicines Australia calls for a focus in planning Australia’s future in health

Health Industry Hub | August 4, 2020 |

Pharma News: Medicines Australia Chief Executive Officer, Elizabeth de Somer has urged a focus on planning for the future – […]

More


News & Trends - Medical Technology

MedTech News - Australian-first procedure for chronic pain sufferers

Australian-first procedure for chronic pain sufferers

Health Industry Hub | August 3, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trendsmenu →Medical Technology’ sub-menu.

More


News & Trends - Pharmaceuticals

Pharma News - New PBS listings in lung cancer, epilepsy and ovarian cancer – AstraZeneca, Roche, Pfizer and Emerge Health

New PBS listings in lung cancer, epilepsy and ovarian cancer – AstraZeneca, Roche, Pfizer and Emerge Health

Health Industry Hub | August 3, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trendsmenu →Pharmaceuticals’ sub-menu.

More